Plus, news about Nippon Shinyaku, Atsena, Orna Therapeutics, Ovid Therapeutics, Graviton Bioscience, Eupraxia, Entero Therapeutics, Journey Therapeutics, Theravance Biopharma, Alpha Cognition and Travere Therapeutics: …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Researchers reviewed the immune mechanisms employed by existing vaccines for invasive pneumococcal disease.
A groundbreaking technology with immense potential in treating ischemic retinopathy in premature infants and diabetic patients has been developed by Professor Byoung Heon Kang and
Alexander has two decades of experience in biotechnology. Credit: Flagship Pioneering/PR Newswire. Flagship Pioneering-founded Valo Health has announced the appointment of Dr Brian Alexander as